中文名称 | 英文名称 | CAS号 | 化学式 | 分子量 |
---|---|---|---|---|
—— | phenylmethyl ((1R)-3-diazo-2-oxo-1-{[(phenylmethyl)sulfanyl]methyl}propyl)methylcarbamate | 914939-84-7 | C20H21N3O3S | 383.471 |
—— | (2R)-2-({2-oxo-2-[(phenylmethyl)oxy]ethyl}amino)-3-[(phenylmethyl)sulfanyl]propanoic acid | 19519-05-2 | C19H21NO4S | 359.446 |
N-苄氧羰基-S-苄基-L-半胱氨酸 | benzyloxycarbonyl-S-benzylcysteine | 3257-18-9 | C18H19NO4S | 345.419 |
—— | phenylmethyl (4R)-5-oxo-4-{[(phenylmethyl)sulfanyl]methyl}-1,3-oxazolidine-3-carboxylate | 519156-45-7 | C19H19NO4S | 357.43 |
N-Methyl β-amino acids are potentially useful amino acid derivatives for incorporation in lead peptide therapeutics. The syntheses of five such compounds are presented. Their synthesis via 6-oxazinanones was low yielding. Alternatively, reductive cleavage of a 5-oxazolidinone gave the N-methyl α-amino acid, which was then homologated via an Arndt–Eistert procedure in high yield to give the N-methyl β-amino acid.